AC
RCUS icon

AXQ Capital’s Arcus Biosciences RCUS Stock Holding History

AXQ Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
+8,254
New +$204K 0.03% 658
2025
Q1 		– Sell
-10,761
Closed -$160K – 657
2024
Q4 		$160K Buy
+10,761
New +$176K 0.07% 351
2023
Q1 		– Sell
-11,490
Closed -$238K – 613
2022
Q4 		$238K Buy
+11,490
New +$316K 0.17% 229

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AXQ Capital's RCUS Position: Q2 2026 in Review

AXQ Capital opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 8,254 shares worth $254K. The stake represents 0.03% of the portfolio and ranks #658 among its holdings. This is a return to the name: AXQ Capital previously reported a position in RCUS as recently as Q4 2024.

AXQ Capital first reported a position in RCUS in Q4 2022 and has held it in 3 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • AXQ Capital held 8,254 shares of Arcus Biosciences worth $254K as of Q2 2026.
  • Arcus Biosciences was a new AXQ Capital position in Q2 2026.
  • Arcus Biosciences made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #658 holding.
  • AXQ Capital first reported a position in Arcus Biosciences in Q4 2022 and has held it in 3 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.